About Us  |   Contact Us  |   Register  | Login  |   

Follow HedgeWorld on Twitter HedgeWorld on LinkedIn






HEDGEWORLD NEWS
Search the News
Advanced News Search
HedgeWorld News by Region
United States / Americas
Europe
Asia / Australia
International
HedgeWorld News Sections
Managed Futures & Derivatives
Daily News
Regulatory/Legal
Strategies/Analysis
Technology
Opinion
People
Indexes
Other News Features
Most Popular
LexisNexis Headlines
Reuters Headlines
The HedgeWorld Blog
Alternative Advantage Daily Newsletter
RSS Service
Sign Up For Email News Alerts
Reprints



Ex-Morgan Stanley broker pleads guilty in insider trading case
09/30/2013 Email this story  |  Printable Version

By Jonathan Stempel

Sept 30 (Reuters) - A former Morgan Stanley financial adviser pleaded guilty to an insider trading charge for tipping a childhood friend to Gilead Sciences Inc's plan in 2011 to buy Pharmasset Inc, three days before the $11.2 billion takeover was announced, court and regulatory records show.

Kevin Dowd, 38, on Monday pleaded guilty to conspiracy to commit securities fraud before U.S. District Judge Anne Thompson in Trenton, New Jersey.

The Boca Raton, Florida resident faces up to five years in prison and a $250,000 fine when he is sentenced on Jan. 15, 2014.

Dowd's plea was announced by U.S. Attorney Paul Fishman in New Jersey.

Peter Willis, a lawyer for Dowd, did not immediately respond to a request for comment.

According to court papers, Dowd learned about the pending merger from a Pharmasset director, who had been the largest customer of the Aventura, Florida branch where Dowd had worked.

Prosecutors said Dowd on Nov. 18, 2011 told his friend about the merger, prompting the friend to buy $196,000 of Pharmasset stock and pass on the tip to another investor who bought Pharmasset call options, also betting the stock would rise.

Those bets paid off after the merger of the two makers of antiviral drugs was announced on Nov. 21, 2011, valuing Princeton, New Jersey-based Pharmasset at a roughly 89 percent premium over its share price at the time.

Prosecutors said Dowd's friend netted a $163,621 profit after buying $195,808 of Pharmasset stock, while the other investor netted a $544,706 profit on the stock options.

According to prosecutors, Dowd admitted to receiving a $35,000 cashier's check in exchange for the initial tip.

Dowd's friend and the person tipped by that friend are identified only by their initials in court papers.

Brokerage records show that Dowd worked for Morgan Stanley Smith Barney in Aventura at the time of the tip, but is no longer registered with a brokerage.

Morgan Stanley said after Dowd's arrest in January that it had cooperated with authorities, and that Dowd had been fired in December 2012.

Gilead is based in Foster City, California.

The case is U.S. v. Dowd, U.S. District Court, District of New Jersey, No. 13-cr-00636.


Email This Story to a Friend   |   Display Printable Version of This Story

Story Copyright © 1999-2014 Reuters HedgeWorld All rights reserved.

HedgeWorld News is sponsored by:






Lipper    Privacy   User Policy  Legal Disclosure Copyright/DMCA  Site Map    FAQ    Glossary  Thomson Reuters for Hedge Funds
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of HedgeWorld content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. HedgeWorld is a registered trademark of Thomson Reuters.